Skip to main content
. 2017 Sep 13;26(10):2059–2072. doi: 10.1002/pro.3243

Table 2.

Anti‐ricin and Anti‐lumazine Synthase Antibody Titers in Sera of Mice Immunized with LS_PB10 Constructs

Treatment Mouse # Anti‐ricin end‐point titer Day 42 Anti‐ricin end‐point titer Day 84 Anti‐lumazine synthase end‐point titer Day 84
1 1600 800 100000
LS_PB10_12 2 400 400 50000
3 400 100 NT*
1 50 100 NT
LS_PB10_12CL 2 0 200 200000
3 100 3200 200000
1 200 400 50000
LS_PB10_34 2 0 100 200000
3 0 100 100000
1 400 >3200 50000
LS_PB10_34CL 2 200 >3200 100000
3 100 100 50000
1 50 3200 NT
LS_PB10_56 2 50 1600 50000
3 0 400 NT
1 0 200 50000
LS_PB 10_56CL 2 3200 1600 200000
3 100 400 400000
1 200 1600 100000
LS_PB10_78 2 100 400 200000
3 100 800 100000
1 0 200 50000
LS_PB10_78CL 2 50 200 200000
3 0 100 100000

Groups of mice (n = 3 mice/group) were immunized with 100 µg of LS_PB10 constructs. Serum samples were collected from the mice after the second (Day 42) and third (Day 84) immunizations. NT indicates “not tested” because of insufficient sample volume for analysis. The anti‐ricin end‐point titers for the group treated with LS were not detected and therefore not shown.